Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brian J. Bolwell"'
Autor:
John W. Sweetenham, Deepa Jagadeesh, Meredeth Shelley, Brian J. Bolwell, Brian T. Hill, Mitchell R. Smith, Brad Pohlman, Robert M. Dean, Stephen D. Smith
Publikováno v:
Leukemia & Lymphoma. 59:690-694
B-cell non-Hodgkin lymphomas (NHL) display dysregulation of pathways controlling cell proliferation and apoptosis. Combined proteasome and mTOR inhibition, demonstrated with bortezomib and everolimus in a preclinical model, thus warrants evaluation i
Autor:
Brian T. Hill, Ronald Sobecks, Steven Andresen, Brian J. Bolwell, Brad Pohlman, John Sweetenham, Matt Kalaycio, Edward A. Copelan, Stephen D. Smith, Robert M. Dean, Lisa Rybicki, Shawnda Tench
Publikováno v:
Leukemia & Lymphoma. 52:986-993
Hyper-CVAD (fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate) is an intense chemotherapy regimen frequently used for hematologic malignancies including mantle cell lymphoma. To addre
Autor:
Brad Pohlman, Ronald Sobecks, Brian J. Bolwell, Josephine Chan, Shawnda Tench, Lisa Sproat, Lisa Rybicki, Robert M. Dean, Steven Andresen, John Sweetenham, Matt Kalaycio, Edward A. Copelan
Publikováno v:
Leukemia & Lymphoma. 51:1-6
Patients with acute myeloid leukemia (AML) with intermediate or high risk cytogenetics are often considered for allogeneic hematopoietic stem cell transplant (AHSCT) in first remission. Between attainment of remission and AHSCT, post-remission chemot
Publikováno v:
Journal of Psychosocial Oncology. 22:1-20
Data from 131 consecutive adult patients who underwent allogeneic bone marrow transplantation (BMT) at a tertiary care center from 1997 to 1999 suggest that the presence of an in-hospital lay care-partner during the patients' hospital stay is a power
Autor:
Brian J. Bolwell, Maciej Zborowski, Lee R. Moore, Masayuki Nakamura, Kara E. McCloskey, Jeffrey J. Chalmers, Mauricio Hoyos
Publikováno v:
Separation Science and Technology. 37:745-767
A continuous flow, magnetic separation method has been proposed to isolate large numbers of cells for clinical and biotechnological applications. The separation system, based on the quadrupole magnet flow sorter, has been tested on magnetically label
Autor:
L. Pineiro, Stacy A. Goodman, Roger H. Herzig, Linda J. Goldsmith, John P. Greer, R Brown, Joseph P. Lynch, Brian J. Bolwell, Geoffrey P. Herzig, Don A. Stevens, Richard S. Stein, Steven N. Wolff, Robert H. Collins, Joseph W. Fay, Donald R. Fleming
Publikováno v:
Leukemia & Lymphoma. 35:91-98
To determine the long-term results of high-dose chemotherapy and stem cell support in relapsed or primary refractory Hodgkin disease patients. One hundred and thirty-one patients with relapsed or primary refractory Hodgkin's disease were treated with